Search clinical trials for: Pegylated Liposomal Doxorubicin Hydrochloride
Total 1358 results
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingOvarian Serous Adenocarcinoma | Primary Peritoneal Serous Adenocarcinoma | Recurrent Ovarian Low Grade Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Recurrent Primary Peritoneal Serous AdenocarcinomaUnited States, United Kingdom
-
National Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Fallopian Tube Transitional Cell Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Fallopian Tube Clear... and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Fox Chase Cancer CenterCompletedFallopian Tube Cancer | Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
National Cancer Institute (NCI)CompletedCombination Chemotherapy With or Without Trastuzumab in Treating Women With Metastatic Breast CancerStage IV Breast Cancer | Recurrent Breast CancerUnited States
-
Fudan UniversityRecruiting
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.; Ortho Biotech, Inc.TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
NYU Langone HealthNational Cancer Institute (NCI)CompletedSarcoma | Ovarian Cancer | Fallopian Tube Cancer | Endometrial CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)Terminated
-
Cancer Institute and Hospital, Chinese Academy...CSPC Ouyi Pharmaceutical Co., Ltd.UnknownHER2-positive Breast CancerChina
-
Fudan UniversityRecruitingHigh-Risk Localized Soft Tissue SarcomaChina
-
University of ArizonaTerminatedBreast CancerUnited States
-
Spanish Breast Cancer Research GroupSchering-PloughCompleted
-
InxMed (Shanghai) Co., Ltd.Active, not recruitingLocally Advanced or Metastatic Solid TumorsChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States, Norway
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Stage III Fallopian Tube Cancer AJCC v7 | Stage III Ovarian Cancer AJCC v6 and v7 | Stage III Primary Peritoneal Cancer AJCC v7 | Stage III Uterine Corpus... and other conditionsUnited States
-
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...Completed
-
Yong ChenUnknownStage III Adult Soft Tissue SarcomaChina
-
AGC Biologics S.p.A.Completed
-
AGC Biologics S.p.A.CompletedOvarian CancerItaly, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Fudan UniversityNot yet recruiting
-
Merck Sharp & Dohme LLCTerminated
-
Fudan UniversityRecruitingAdvanced Malignant TumorsChina
-
Luye Pharma Group Ltd.CompletedAdvanced Breast CancerChina
-
Dr. Reddy's Laboratories LimitedCompletedOvarian Epithelial Cancer RecurrentIndia
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Completed
-
Case Comprehensive Cancer CenterRecruitingRelapsed SarcomasUnited States
-
Roswell Park Cancer InstituteOrtho Biotech, Inc.Completed
-
The University of Texas Health Science Center,...UnknownCervical Cancer | Breast Cancer | Ovarian Cancer | Endometrial CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyActive, not recruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Kasr El Aini HospitalCompletedRadial Artery Injury PrevetionEgypt
-
Seoul National University HospitalUnknownHigh Grade Serous Carcinoma | Ovarian Neoplasm EpithelialKorea, Republic of
-
Merck Sharp & Dohme LLCTerminated
-
Johnson & Johnson Pharmaceutical Research & Development...Centocor Ortho Biotech Services, L.L.C.Withdrawn
-
Sun Yat-sen UniversityUnknownUnrecognized Condition
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Undifferentiated Ovarian CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingMalignant Solid NeoplasmUnited States
-
The Netherlands Cancer InstituteUnknownMeningeal CarcinomatosisNetherlands
-
Hellenic Oncology Research GroupUniversity Hospital of CreteTerminated
-
Millennium Pharmaceuticals, Inc.WithdrawnOvarian CancerItaly, Switzerland
-
Merck Sharp & Dohme LLCPrincess Margaret Hospital, CanadaCompleted
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Breast Cancer | Ovarian Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
SOLTI Breast Cancer Research GroupSchering-PloughCompleted
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cheng-Kung University HospitalCompletedFallopian Tube Cancer | Peritoneal Carcinoma | Ovarian Neoplasms Malignant (Excl Germ Cell)
-
CelgeneGynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerUnited States
-
Peking University People's HospitalXijing Hospital; Peking Union Medical College Hospital; Chinese PLA General Hospital and other collaboratorsWithdrawnToxicity | Overall Survival | Progression-free SurvivalChina
-
Novo Nordisk A/SCompletedCancer | Ovarian CancerGermany, France
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USATerminatedMetastatic Breast CancerUnited States